Buyout of novamed prompts shareholder claims investigation by goldfarb branham law firm llp

Dallas--(business wire)--goldfarb branham llp is investigating whether the board of directors of novamed, inc. (nasdaq: nova) violated shareholder protection laws by agreeing to sell the company to surgery center holdings, inc. for $13.25 per share. shareholders – or anyone with knowledge of the transaction – are encouraged to contact hamilton lindley at 877-583-2855 or hlindley@goldfarbbranham.com. “this transaction appears undervalued because the buyout price offers no premium over the $13.00 share price that novamed stock traded for as recently as january 18, 2011, and also because at least one analyst believes that the stock is worth $18 per share,” said securities lawyer hamilton lindley. “our proposed class action lawsuit seeks to maximize the amount of money and information to shareholders of novamed in this transaction." goldfarb branham’s lawyers have significant experience representing individual and institutional investors in over 100 shareholder class action cases. a firm securities lawyer, hamilton lindley, can be reached at hlindley@goldfarbbranham.com or 877-583-2855 to discuss the impact of this buyout on novamed shareholders.
NOVA Ratings Summary
NOVA Quant Ranking